Since 1987, when chemopreventive testing programs began, more than 1,000 agents and agent combinations have been selected and evaluated in preclinical studies of chemopreventive activity against various types of cancers. In the present study we aimed to provide quantitative and qualitative characterization of biological and pharmacological activities of ICD-85 on MDA-MB-231 cell line (a highly invasive breast cancer cell line) in order to gain a better understanding of the cytotoxic and apoptotic effects of this compound. For this study, the MDA-MB-231 cell line was used and the effect of ICD-85 was assayed by measuring the activity of the cytosolic enzyme lactate dehydrogenase (LDH), released into the culture medium after membrane damage. Morphological alterations of cells were investigated in the control group and cells incubated with ICD-85 as cytotoxic agent. Results showed, in the test group, that cells incubated with 16 μg/mL of ICD-85 had decreased cytoplasmic branching. Some cells were had ruptured and lost the continuity of their surrounding membranes while some had shrunk. Cells incubated with higher doses (above16 μg/mL) showed similar changes towards cellular normality with more severity. Results obtained from the ICD-85 stability test reveal that the effect of ICD-85 on MDA-MB-231 cell line in culture medium is stable throughout the incubation time period (24 hours). It appears that ICD-85 at higher concentrations acts at the membrane level, which allows the passage of ions down the concentration gradient, resulting in osmotic changes in organelles followed by several unidentified mechanisms leading to cell death. At lower concentrations, it appears that ICD-85 can prevent cell growth by another mechanism, which may be one of the causes for apoptosis in the cell line.
INTRODUCTION
Although advances have been achieved in adjuvant therapies for breast cancer, many treatments cause significant and potentially life-threatening side effects such as cardiotoxicity (8, 9) . A chemoprevention study is defined as the use of specific chemical compounds to prevent, inhibit or reduce cell growth. Since 1987, during chemoprevention testing programs, more than 1,000 agents and agent combinations have been selected and evaluated in preclinical studies of chemopreventive activities, ranging from in vitro mechanistic assays and cell-based transformation assays to carcinogen-induced and transgenic animal models (1, 7, 17) . New agents are continuously considered for development as chemopreventive drugs, whose selection is based on preliminary efficacy data, mechanistic considerations and potential for improving chemopreventive index (2) .
There are reports that present the cytotoxic activity of various snake venoms, in vitro and in vivo, by employing melanoma and chondrosarcoma cells (5) . It was further demonstrated that a purified protein from cobra venom was selectively cytotoxic to cancer cells (4, 6) . Silva et al. (15) evaluated the action of the venoms from Crotalus durissus terrificus and Bothrops jararaca on Ehrlich ascites tumors and found that both venoms act directly on tumor cells. They further postulated the various mechanisms involved in the anti-tumor activity. In the present study we aimed to characterize, quantitatively and qualitatively, the biological and pharmaceutical activities of ICD-85 (biologically active peptides from venomous animals) on MDA-MB-231 cell line in order to gain a better understanding of the cytotoxic, apoptotic and necrotic effects of this compound as a chemopreventive agent.
MATERIALS AND METHODS

ICD-85
The active fraction of ICD-85 is a combination of three peptides, ranging from 10,000 to 30,000 Da, derived from the venoms of an Iranian brown snake (Agkistrodon halys) and a yellow scorpion (Hemiscorpius lepturus). This fraction was formulated and provided by the corresponding author. The ICD-85 peptides were selected based on a study of crude venom cytotoxicity. The crude venom showed antigrowth activity on the MBA-MD231 cell line. Then, the venoms were fractionated, the active peptides were isolated and, subsequentially, tested on the same cell line. Enzymatic characterization of the peptides was not performed. 
Cell Line
The MDA-MB-231 breast cancer cell line was kindly provided by Professor Holger Kalthoff from Christian-Albrechts University (Kiel, Germany). These cells were plated in suitable culture flasks in Dulbecco's Modified Eagle's Medium (DMEM) (Sigma, Germany) supplemented with 10% fetal calf serum and 1% L-glutamin plus 0.5% penicillin/streptomycin and incubated at 37°C (10, 11) .
Quantification of ICD-85 Cytotoxicity
Cells used in this study were harvested by trypsination (0.5% trypsin in phosphate- Toxicity was assayed by measuring the activity of the cytosolic enzyme, lactate dehydrogenase (LDH), released into the culture medium after membrane damage.
Samples from clarified medium of treated and untreated control wells were taken after intervals of 0.5, 1, 2, 4 and 8 hours of incubation and the LDH activity was measured using the cytotoxicity assay, CytoTox 96® (Promega, USA) associated with a fully automated microplate reader photometer. Damage and morphological changes in the cell line were investigated by light phase contrast microscopy and photos were taken at each evaluation moment.
Stability of ICD-85 in Culture
To examine variations of ICD-85 activity in the liquid medium, culture medium containing ICD-85 at the lowest concentration (1 μg/mL) was incubated at 37°C in a fully humidified atmosphere. After a 24-hour incubation, ICD-85 solution samples
were tested on the MDA-MB-231 cell line by measuring LDH. 
Statistical Analysis
Data were analyzed using student's t-test with statistical significance for p < 0.05.
RESULTS
The 
DISCUSSION
Evidence from basic research and from experiments on animal models and cell culture systems supports the concept that several compounds, including natural products, may offer protection against organ site carcinogenesis (3, 16). These biological products or natural phytochemicals, either as single agents or as adjuvants, may represent valuable lead compounds for preventive or therapeutic interventions (6).
Crude snake venoms and their isolated peptides have proven effective cancer cell inhibitors (12) (13) (14) .
The MDA-MB-231 cell line was employed in the current study due to its extremely invasive behavior (10, 11) . This investigation showed that the damage induced in the cell line by ICD-85 is direct. The cytotoxicity was remarkable and cell survival was reduced by the two highest concentrations (64 and128 μg/mL). Considering the rapid effects observed within 30 minutes -including the lysis of organelle membranes that immediately caused cell death -we suggest that this biological product (ICD-85) acts at the membrane level at high concentrations. The cytotoxicity assay that measured that a new biologically active drug against cancer will be developed.
